go back

Lisocabtagene Maraleucel (Breyanzi)

California rates for HCPCS C9076

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $426,580 · 10th–90th $426,580$426,5800%50%100%$426,580Professionalmedian $489,779 · 10th–90th $129$645,6540%20%40%10th90th$489,779$100.0$500.0$2.0K$10.0K$50.0K$200.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$128.82
Median
$398.11
Typical High
$831.76
Lucent Health
Setting
Facility
Modifier
Global
Typical Low
$426,579.52
Median
$426,579.52
Typical High
$426,579.52
Lucent Health
Setting
Professional
Modifier
Global
Typical Low
$645,654.23
Median
$645,654.23
Typical High
$645,654.23
United
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$537,031.80